Trial Profile
A retrospective study in metastatic melanoma patients treated with concurrent ipilimumab and radiotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Aug 2016
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 21 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.